Follow
yemi oluboyede
yemi oluboyede
health economics
Verified email at ncl.ac.uk - Homepage
Title
Cited by
Cited by
Year
Non‐pharmacological approaches for dementia that informal carers might try or access: a systematic review
C Hulme, J Wright, T Crocker, Y Oluboyede, A House
International journal of geriatric psychiatry 25 (7), 756-763, 2010
1882010
What is the value of routinely testing full blood count, electrolytes and urea, and pulmonary function tests before elective surgery in patients with no apparent clinical …
C Czoski-Murray, ML Jones, C McCabe, K Claxton, Y Oluboyede, ...
Health technology assessment (Winchester, England) 16 (50), i, 2012
1232012
Continuous low-dose antibiotic prophylaxis for adults with repeated urinary tract infections (AnTIC): a randomised, open-label trial
H Fisher, Y Oluboyede, T Chadwick, M Abdel-Fattah, C Brennand, ...
The Lancet infectious diseases 18 (9), 957-968, 2018
1032018
Effectiveness and acceptability of parental financial incentives and quasi-mandatory schemes for increasing uptake of vaccinations in preschool children: systematic review …
J Adams, B Bateman, F Becker, T Cresswell, D Flynn, R McNaughton, ...
Health technology assessment 19 (94), 1-176, 2015
942015
A randomised 2 x 2 trial of community versus hospital pulmonary rehabilitation, followed by telephone or conventional follow-up.
JC Waterhouse, SJ Walters, Y Oluboyede, RA Lawson
Health technology assessment (Winchester, England) 14 (6), i-v, vii, 2010
792010
Updated cost-effectiveness analysis of trastuzumab for early breast cancer: a UK perspective considering duration of benefit, long-term toxicity and pattern of recurrence
PS Hall, C Hulme, C McCabe, Y Oluboyede, J Round, DA Cameron
Pharmacoeconomics 29, 415-432, 2011
752011
Cost effectiveness of chest pain unit care in the NHS
Y Oluboyede, S Goodacre, A Wailoo, ...
BMC Health Services Research 8, 1-9, 2008
412008
Health-related quality of life and patient-reported outcome measures in NASH-related cirrhosis
L McSweeney, M Breckons, G Fattakhova, Y Oluboyede, L Vale, ...
JHEP Reports 2 (3), 100099, 2020
392020
The factor structure of the GHQ-12: the interaction between item phrasing, variance and levels of distress
AB Smith, Y Oluboyede, R West, J Hewison, AO House
Quality of Life Research 22, 145-152, 2013
382013
Performance of non-invasive tests and histology for the prediction of clinical outcomes in patients with non-alcoholic fatty liver disease: an individual participant data meta …
FE Mózes, JA Lee, Y Vali, O Alzoubi, K Staufer, M Trauner, R Paternostro, ...
The Lancet Gastroenterology & Hepatology, 2023
312023
Continuous low-dose antibiotic prophylaxis to prevent urinary tract infection in adults who perform clean intermittent self-catheterisation: the AnTIC RCT
R Pickard, T Chadwick, Y Oluboyede, C Brennand, ...
Health Technology Assessment, 2018
302018
A randomised 2× 2 trial of community versus hospital pulmonary rehabilitation for chronic obstructive pulmonary disease followed by telephone or conventional follow-up
JC Waterhouse, SJ Walters, Y Oluboyede, RA Lawson
Health Technol Assess 14 (6), 1-164, 2010
272010
Economic evaluations of alcohol prevention interventions: Is the evidence sufficient? A review of methodological challenges
SR Hill, L Vale, D Hunter, E Henderson, Y Oluboyede
Health Policy 121 (12), 1249-1262, 2017
232017
Development and refinement of the WAItE: a new obesity-specific quality of life measure for adolescents
Y Oluboyede, C Hulme, A Hill
Quality of Life Research 26, 2025-2039, 2017
182017
Measuring health outcomes of adolescents: report from a pilot study
Y Oluboyede, S Tubeuf, C McCabe
The European Journal of Health Economics 14, 11-19, 2013
172013
Measuring health-related quality of life in the general population and Roma communities in Romania: study protocol for two cross-sectional studies
E Olariu, MS Paveliu, E Baican, Y Oluboyede, L Vale, IG Niculescu-Aron
BMJ open 9 (8), e029067, 2019
142019
Measuring weight-specific quality of life in adolescents: an examination of the concurrent validity and test-retest reliability of the WAItE
Y Oluboyede, T Robinson
Value in Health 22 (3), 348-354, 2019
142019
Evidence for a unidimensional 15-item version of the CASP-19 using a Rasch model approach
Y Oluboyede, AB Smith
Quality of Life Research 22, 2429-2433, 2013
132013
Estimating CHU-9D utility scores from the WAItE: a mapping algorithm for economic evaluation
T Robinson, Y Oluboyede
Value in Health 22 (2), 239-246, 2019
112019
Triangulation and integration of results
J Adams, B Bateman, F Becker, T Cresswell, D Flynn, R McNaughton, ...
Effectiveness and acceptability of parental financial incentives and quasi …, 2015
102015
The system can't perform the operation now. Try again later.
Articles 1–20